Types of articles for submission
Review articles, research or original articles, or rapid clinical communications are appropriate for submission to this journal.
Items needed for manuscript submission
The submission should include the following items:
1) Manuscript. The author should submit a complete manuscript including title page, abstract, text, references, tables, figures and legends. The text of an original article should include the following sections: introduction, materials and methods, results, discussion, and acknowledgements. The total text length of a review article or original research article cannot exceed 6,000 words.
2) Figures. Figures should be in separate files in TIFF of JPEG format. The minimum resolution for images is 300 dpi. A review article should contain at least 2 figures, and the number of figures for an original research article should be between 3 and 8.
3) Cover letter. A cover letter must accompany every manuscript submission. The letter should contain the following:
- The corresponding author’s name, telephone and fax numbers, and postal and e-mail addresses.
- The title of the manuscript and a brief paragraph explaining the significance of the work.
- The type of manuscript.
- A statement that the submitted manuscript is an original and unpublished work of the listed authors and is not under simultaneous consideration for publication by any another journal.
- Any conflicts of interest.
- The names, institutional affiliations, and postal and e-mail addresses of 3-5 qualified reviewers.
Requirements for manuscripts
The following parts of a manuscript must be included and should meet the requirements listed below.
The title page should carry the following information: (1) The full title of the paper, not exceeding 120 characters (including spaces) and avoiding abbreviations. (2) The full name of all authors. (3) The name(s) and address(es) of the institution(s) where the work was performed. (The present addresses of the authors, if different from the above, should appear in a footnote.) (4) The name, mailing address, telephone number, fax number and e-mail address of the author responsible for correspondence about the manuscript (corresponding author). (5) A running title, usually no more than 40 characters (including letters and spaces), at the foot of the title page.
The abstract should not exceed 250 words and should be followed by appropriate keywords up to a maximum of six. The abstract should provide the context or background for the study and should state the study’s purpose, basic procedures, main findings, and principal conclusions. It should emphasize new and important aspects of the study or observations.
The introduction should provide a context or background for the study. It should state the specific purpose or research objective of, or hypothesis tested by, the study or observation.
The methods and materials section should include the methods, apparatus (including the manufacturer’s name in parentheses), and procedures in sufficient detail to allow others to reproduce the results, including the following: references to established methods; references and brief descriptions for methods that have been published but are not well-known; information about all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration; and description of statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results.
The results section should describe or summarize the most important findings in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data from the tables or illustrations.
The discussion section should describe the new and important aspects of the study and explore possible mechanisms or explanations for these findings; compare and contrast the results with other relevant studies; state the limitations of the study; and explore the implications of the findings for future research and for clinical practice.
The conflicts of interest statement requires authors to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. If no competing interests are declared, the statement will read as follows: “The authors declare that they have no conflicts of interest.”
The acknowledgements section should recognize anyone who made substantial contributions to the research conception or design; the acquisition, analysis or interpretation of data; or anyone who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. This section should also include the source(s) of funding for each author and for the manuscript preparation as well as anyone who contributed materials essential for the study.
The list of references must be placed at the end of the manuscript text. Please note that authors are responsible for the accuracy and completeness of their references. For reference style, please refer to the style guidelines for the Journal of Neuroscience. There is no limit on the number of references.
Legends should accompany all figures and tables, and must be included in the manuscript after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. References in legends should be specific -- for example, "See Results” rather than “See text.”
Author agreement and statement
Authors must include an authors’ statement and agreement containing the text below.
Statement: “We certify that we are the only authors of the article, are authorized to submit the article to Conditioning Medicine, and are not in breach or violation of any other obligation by granting publication rights to Conditioning Medicine. In addition, the following statements are true:
- “The article is original and has not been published in any other peer-reviewed journal. It is not being considered for publication by any other journal and does not violate the rights of any copyright owner;
- “The article contains no language that is unlawful, libelous, or in violation of a contract or confidentiality agreement;
- “To our knowledge, all factual statements in the article are true.
- “There is no formula or procedure described in the article that, if followed precisely as described, would cause any injury, illness or damage to persons following the formula or procedure.”
Agreement: “In submitting this article to Conditioning Medicine, the authors accept the following license agreement:
- “Anyone is free to copy, distribute, and display this article;
- “Anyone is free to create works derived from this article;
- “Anyone is free to make noncommercial use of this article provided that these conditions are met: a) the original authors and publisher must be clearly and fully attributed; b) with any reuse or distribution of the article, the license terms must be made clear; and c) in the event that the original authors later republish the article in other journals or publications, the authors agree to acknowledge Conditioning Medicine as a source.”